<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="case-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Intern Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Intern. Med</journal-id>
<journal-title-group>
<journal-title>Internal Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">0918-2918</issn>
<issn pub-type="epub">1349-7235</issn>
<publisher>
<publisher-name>The Japanese Society of Internal Medicine</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29033429</article-id>
<article-id pub-id-type="pmc">5799065</article-id>
<article-id pub-id-type="doi">10.2169/internalmedicine.9052-17</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cowden Syndrome with a Novel <italic>PTEN</italic> Mutation Presenting with Partial Epilepsy Related to Focal Cortical Dysplasia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Adachi</surname>
<given-names>Tadashi</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Takigawa</surname>
<given-names>Hiroshi</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nomura</surname>
<given-names>Takashi</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Watanabe</surname>
<given-names>Yasuhiro</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kowa</surname>
<given-names>Hisanori</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<aff id="aff1">
<label>1</label>Division of Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Japan</aff>
</contrib-group>
<author-notes>
<fn>
<p>Correspondence to Dr.　Tadashi Adachi, <email>adachi.neuro@gmail.com</email></p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<day>1</day>
<month>1</month>
<year>2018</year>
</pub-date>
<volume>57</volume>
<issue>1</issue>
<fpage>97</fpage>
<lpage>99</lpage>
<history>
<date date-type="received">
<day>16</day>
<month>2</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>5</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 by The Japanese Society of Internal Medicine</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
<license-p><!--CREATIVE COMMONS-->The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Cowden syndrome is a rare autosomal dominant disorder characterized by multiple hamartomas of the ectoderm and brain. A 36-year-old Japanese man presented with right facial seizure during sleep and was admitted to our hospital. He showed cobblestoning over the tongue and palmar pitting but no neurological abnormalities while he was not having a seizure. Brain magnetic resonance imaging showed focal cortical dysplasia in the left frontal lobe. Electroencephalography showed sharp waves over the left frontal lesion. A genetic analysis revealed a novel mutation of <italic>PTEN.</italic> The administration of carbamazepine ended the seizures. This is the first Japanese case of Cowden syndrome with a novel <italic>PTEN</italic> gene mutation and cortical dysplasia. </p>
</abstract>
<kwd-group kwd-group-type="author">
<kwd>Cowden syndrome</kwd>
<kwd>cortical dysplasia</kwd>
<kwd>
<italic>PTEN</italic>
</kwd>
<kwd>epilepsy</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec>
<title>Introduction</title>
<p>Cowden syndrome is a rare disorder caused by autosomal dominant mutations in the <italic>phosphatase and tensin homologue on chromosome 10</italic> (<italic>PTEN</italic>) tumor suppressor gene. Cowden syndrome is characterized by multiple hamartomas, particularly of the skin and gastrointestinal system, and is frequently associated with breast, thyroid, and genitourinary malignancies (<xref ref-type="bibr" rid="B1">1</xref>). In a study of 20 patients with Cowden syndrome, 7 (35%) had abnormalities on brain magnetic resonance imaging (MRI), which included dysplastic cerebellar gangliocytomas, meningiomas, and vascular malformations (<xref ref-type="bibr" rid="B2">2</xref>). However, cerebral cortical dysplasia is a rare manifestation of Cowden syndrome. We herein report a Japanese patient with Cowden syndrome who had cerebral cortical dysplasia, seizures, and a novel <italic>PTEN</italic> mutation.</p>
</sec>
<sec>
<title>Case Report</title>
<p>A 36-year-old man suffered a right facial seizure during sleep. The seizure awakened him and lasted for a few minutes. Three months later, he experienced another right facial seizure during a nap. He reported that this seizure also lasted for a few minutes, and then he lost consciousness. When he regained consciousness, he found vomitus near his pillow and experienced weakness of his right upper and lower limbs for about half a day. After eight days, he was admitted to our hospital. He had no family history of epilepsy or neurological disorders, but his father died of hepatocellular carcinoma. His birth and growth were normal, and he had no history of epilepsy or febrile convulsions, but he noticed bilateral palmar pitting as a teenager. His general condition was good, and his vital signs were within normal limits. He showed macrocephaly, and a skin examination revealed cobblestoning over the cheek and tongue (<xref ref-type="fig" rid="g001">Fig. 1</xref>) and palmar pitting. He showed no neurological abnormalities during his time without seizures and no cognitive decline, aphasia, or apraxia, and he achieved a full score on the Mini-Mental State Examination. Blood tests for autoantibodies, amino acids, lactate, pyruvate, pituitary hormone, tumor markers, and infectious agents showed no abnormalities. An examination of the cerebrospinal fluid revealed normal pressure, no pleocytosis, a protein level of 30 mg/dL, and an IgG index of 0.370; in addition, myelin basic protein was within normal limits, and oligoclonal bands and culture and cytology were negative.</p>
<fig id="g001" orientation="portrait" position="float">
<label>Figure 1.</label>
<caption>
<p>Skin abnormalities in our patient. A skin examination revealed cobblestoning over the cheek (A) and tongue (B).</p>
</caption>
<graphic xlink:href="1349-7235-57-0097-g001"></graphic>
</fig>
<p>Brain MRI showed left frontal focal cortical dysplasia without contrast enhancement and linear T2 hyperintensities of the subcortical white matter (<xref ref-type="fig" rid="g002">Fig. 2</xref>). Positron Emission Tomography-Computed Tomography showed hypometabolism of cortical dysplasia, and Single photon emission computed tomography showed hypoperfusion in this area (<xref ref-type="fig" rid="g002">Fig. 2</xref>). Electroencephalography during wakefulness and sleep showed sharp waves from the left frontal lesion, along with convulsions during sleep. Sensory evoked potentials (SEPs) showed no cortical delay, laterality, or giant SEPs, and <sup>67</sup>Ga scintigraphy showed no abnormal accumulation. A whole-body CT scan showed no hamartomas, even in the thyroid, breast, lung, and liver. Gastrointestinal endoscopy revealed multiple polyps.</p>
<fig id="g002" orientation="portrait" position="float">
<label>Figure 2.</label>
<caption>
<p>Brain MRI images and PET-CT fusion images. The left frontal lobe showed cortical thickening (A; arrow) and linear subcortical T2 hyperintensities (B; arrow) with hypometabolism in this area (C; arrow).</p>
</caption>
<graphic xlink:href="1349-7235-57-0097-g002"></graphic>
</fig>
<p>We obtained written informed consent for genetic testing but did not provide genetic counseling because the patient refused it. All nine exons and exon-intron junctions of the <italic>PTEN</italic> gene were analyzed by polymerase chain reaction direct sequencing. A mutational analysis of <italic>PTEN</italic> showed a heterozygous deletion in exon 5 (c.486delC, <xref ref-type="fig" rid="g003">Fig. 3</xref>). This mutation generally induces pathogenicity causing Cowden syndrome because of a leading stop codon. The patient was diagnosed with Cowden syndrome with a novel <italic>PTEN</italic> mutation and secondary epilepsy due to cortical dysplasia. He was administered carbamazepine, and the convulsions during sleep disappeared.</p>
<fig id="g003" orientation="portrait" position="float">
<label>Figure 3.</label>
<caption>
<p>A mutation analysis of <italic>PTEN</italic> showed a heterozygous deletion in exon 5 (c.486delC).</p>
</caption>
<graphic xlink:href="1349-7235-57-0097-g003"></graphic>
</fig>
</sec>
<sec>
<title>Discussion</title>
<p>Cowden syndrome was first described by Lloyd and Dennis in 1963 and is characterized by macrocephaly, mucocutaneous lesions, acral keratosis, papillamatous papules, and a high risk of developing cancer in the breast, thyroid, and endometrium (<xref ref-type="bibr" rid="B3">3</xref>). This rare autosomal dominant disease has an estimated prevalence of 1 in 100,000 to 250,000 with genetic identification (<xref ref-type="bibr" rid="B4">4</xref>). In 1996, the International Cowden Consortium identified germline <italic>PTEN</italic> mutations as a cause of Cowden syndrome (<xref ref-type="bibr" rid="B5">5</xref>). <italic>PTEN</italic> is a tumor suppressor gene that encodes a key lipid phosphatase in the phosphoinositide 3-kinase signaling cascade (<xref ref-type="bibr" rid="B6">6</xref>) and in cell proliferation and migration (<xref ref-type="bibr" rid="B7">7</xref>).</p>
<p>Cowden syndrome represents a late-onset phenotype of the <italic>PTEN</italic> mutation. Early presentations of <italic>PTEN</italic> mutations include Lhermitte-Duclos disease (dysplastic gangliocytomas in cerebellum), Bannayan-Riley-Ruvalcaba syndrome, and autism spectrum disorder with macrocephaly (<xref ref-type="bibr" rid="B1">1</xref>). An MRI study showed dysplastic gangliocytomas in the cerebellum, meningiomas, and vascular malformations as common abnormalities, occurring in 35% of patients with Cowden syndrome (<xref ref-type="bibr" rid="B2">2</xref>). The underlying etiology of these brain hamartomas is currently unknown. Several cases of Cowden syndrome with cortical dysplasia in childhood have been reported (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>); however, only one case of adult-onset Cowden syndrome with cortical dysplasia has been published (<xref ref-type="bibr" rid="B10">10</xref>).</p>
<p>Recently, <italic>PTEN</italic> mutations have been found to play an important role in cancer and epilepsy, and PI3/Akt/mTOR inhibitors are being investigated as potential treatments (<xref ref-type="bibr" rid="B11">11</xref>). In a mouse model of cortical dysplasia, the PI3/Akt/mTOR inhibitor rapamycin reduced the tumor size and suppressed epileptic discharge and cortical hyperplasia (<xref ref-type="bibr" rid="B12">12</xref>). Furthermore, somatic mutations in the mechanistic target of rapamycin (MTOR) gene also cause focal cortical dysplasia (<xref ref-type="bibr" rid="B13">13</xref>). This evidence suggests that the PI3/Akt/mTOR pathway is closely related to the development of cortical dysplasia. We do not know why cortical dysplasia was present in our patient, but it may have slowly led to the development of his epilepsy in adulthood.</p>
<p>Cowden syndrome is an important differential diagnosis of adult-onset partial epilepsy with cortical dysplasia, and neurologists must check dermatological lesions, hamartomas, and malignant cancers and conduct a gene analysis in such patients.</p>
</sec>
<sec>
<title></title>
<p>
<bold>The authors state that they have no Conflict of Interest (COI).</bold>
</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgement</title>
<p>The authors thank Kaori Adachi and Eiji Nanba for performing the genetic analysis.</p>
</ack>
<ref-list>
<ref id="B1">
<label>1.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Blumenthal</surname><given-names>GM</given-names></name>, <name><surname>Dennis</surname><given-names>PA</given-names></name></person-group>
<article-title>PTEN hamartoma tumor syndromes</article-title>. <source/>Eur J Hum Genet
<volume>16</volume>: <fpage>1289</fpage>-<lpage>1300</lpage>, <year>2008</year>.<pub-id pub-id-type="pmid">18781191</pub-id></mixed-citation>
</ref>
<ref id="B2">
<label>2.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lok</surname><given-names>C</given-names></name>, <name><surname>Viseux</surname><given-names>V</given-names></name>, <name><surname>Avril</surname><given-names>MF</given-names></name>, <etal>et al</etal></person-group>
<article-title>Brain magnetic resonance imaging in patients with Cowden syndrome</article-title>. <source/>Medicine (Baltimore)
<volume>84</volume>: <fpage>129</fpage>-<lpage>136</lpage>, <year>2005</year>.<pub-id pub-id-type="pmid">15758842</pub-id></mixed-citation>
</ref>
<ref id="B3">
<label>3.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lloyd</surname><given-names>KM</given-names><suffix>2nd</suffix></name>, <name><surname>Dennis</surname><given-names>M</given-names></name></person-group>
<article-title>Cowden's disease. A possible new symptom complex with multiple system involvement</article-title>. <source/>Ann Intern Med
<volume>58</volume>: <fpage>136</fpage>-<lpage>142</lpage>, <year>1963</year>.<pub-id pub-id-type="pmid">13931122</pub-id></mixed-citation>
</ref>
<ref id="B4">
<label>4.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Farooq</surname><given-names>A</given-names></name>, <name><surname>Walker</surname><given-names>LJ</given-names></name>, <name><surname>Bowling</surname><given-names>J</given-names></name>, <name><surname>Audisio</surname><given-names>RA</given-names></name></person-group>
<article-title>Cowden syndrome</article-title>. <source/>Cancer Treat Rev
<volume>36</volume>: <fpage>577</fpage>-<lpage>583</lpage>, <year>2010</year>.<pub-id pub-id-type="pmid">20580873</pub-id></mixed-citation>
</ref>
<ref id="B5">
<label>5.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nelen</surname><given-names>MR</given-names></name>, <name><surname>Padberg</surname><given-names>GW</given-names></name>, <name><surname>Peeters</surname><given-names>EA</given-names></name>, <etal>et al</etal></person-group>
<article-title>Localization of the gene for Cowden disease to chromosome 10q22-23</article-title>. <source/>Nat Genet
<volume>13</volume>: <fpage>114</fpage>-<lpage>116</lpage>, <year>1996</year>.<pub-id pub-id-type="pmid">8673088</pub-id></mixed-citation>
</ref>
<ref id="B6">
<label>6.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shen</surname><given-names>WH</given-names></name>, <name><surname>Balajee</surname><given-names>AS</given-names></name>, <name><surname>Wang</surname><given-names>J</given-names></name>, <etal>et al</etal></person-group>
<article-title>Essential role for nuclear PTEN in maintaining chromosomal integrity</article-title>. <source/>Cell
<volume>128</volume>: <fpage>157</fpage>-<lpage>170</lpage>, <year>2007</year>.<pub-id pub-id-type="pmid">17218262</pub-id></mixed-citation>
</ref>
<ref id="B7">
<label>7.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Orrico</surname><given-names>A</given-names></name>, <name><surname>Galli</surname><given-names>L</given-names></name>, <name><surname>Buoni</surname><given-names>S</given-names></name>, <name><surname>Orsi</surname><given-names>A</given-names></name>, <name><surname>Vonella</surname><given-names>G</given-names></name>, <name><surname>Sorrentino</surname><given-names>V</given-names></name></person-group>
<article-title>Novel PTEN mutations in neurodevelopmental disorders and macrocephaly</article-title>. <source/>Clin Genet
<volume>75</volume>: <fpage>195</fpage>-<lpage>198</lpage>, <year>2009</year>.<pub-id pub-id-type="pmid">18759867</pub-id></mixed-citation>
</ref>
<ref id="B8">
<label>8.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cheung</surname><given-names>KM</given-names></name>, <name><surname>Lam</surname><given-names>CW</given-names></name>, <name><surname>Chan</surname><given-names>YK</given-names></name>, <name><surname>Siu</surname><given-names>WK</given-names></name>, <name><surname>Yong</surname><given-names>L</given-names></name></person-group>
<article-title>Atypical focal cortical dysplasia in a patient with Cowden syndrome</article-title>. <source/>Hong Kong Med J
<volume>20</volume>: <fpage>165</fpage>-<lpage>167</lpage>, <year>2014</year>.<pub-id pub-id-type="pmid">24714173</pub-id></mixed-citation>
</ref>
<ref id="B9">
<label>9.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Elia</surname><given-names>M</given-names></name>, <name><surname>Amato</surname><given-names>C</given-names></name>, <name><surname>Bottitta</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group>
<article-title>An atypical patient with Cowden syndrome and PTEN gene mutation presenting with cortical malformation and focal epilepsy</article-title>. <source/>Brain Dev
<volume>34</volume>: <fpage>873</fpage>-<lpage>876</lpage>, <year>2012</year>.<pub-id pub-id-type="pmid">22469695</pub-id></mixed-citation>
</ref>
<ref id="B10">
<label>10.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Child</surname><given-names>ND</given-names></name>, <name><surname>Cascino</surname><given-names>GD</given-names></name></person-group>
<article-title>Mystery case: Cowden syndrome presenting with partial epilepsy related to focal cortical dysplasia</article-title>. <source/>Neurology
<volume>81</volume>: <fpage>e98</fpage>-<lpage>e99</lpage>, <year>2013</year>.<pub-id pub-id-type="pmid">24062348</pub-id></mixed-citation>
</ref>
<ref id="B11">
<label>11.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rodgers</surname><given-names>SJ</given-names></name>, <name><surname>Ferguson</surname><given-names>D</given-names></name>, <name><surname>Mitchell</surname><given-names>C</given-names></name>, <name><surname>Ooms</surname><given-names>L</given-names></name></person-group>
<article-title>Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases</article-title>. <source/>Biosci Rep
<year>2017</year>(Epub ahead of print).</mixed-citation>
</ref>
<ref id="B12">
<label>12.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>LH</given-names></name>, <name><surname>Brewster</surname><given-names>AL</given-names></name>, <name><surname>Clark</surname><given-names>ME</given-names></name>, <etal>et al</etal></person-group>
<article-title>mTOR inhibition suppresses established epilepsy in a mouse model of cortical dysplasia</article-title>. <source/>Epilepsia
<volume>56</volume>: <fpage>636</fpage>-<lpage>646</lpage>, <year>2015</year>.<pub-id pub-id-type="pmid">25752454</pub-id></mixed-citation>
</ref>
<ref id="B13">
<label>13.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nakashima</surname><given-names>M</given-names></name>, <name><surname>Saitsu</surname><given-names>H</given-names></name>, <name><surname>Takei</surname><given-names>N</given-names></name>, <etal>et al</etal></person-group>
<article-title>Somatic Mutations in the MTOR gene cause focal cortical dysplasia type IIb</article-title>. <source/>Ann Neurol
<volume>78</volume>: <fpage>375</fpage>-<lpage>386</lpage>, <year>2015</year>.<pub-id pub-id-type="pmid">26018084</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>